Stay updated on AXS-05 in Alzheimer's Agitation Clinical Trial
Sign up to get notified when there's something new on the AXS-05 in Alzheimer's Agitation Clinical Trial page.

Latest updates to the AXS-05 in Alzheimer's Agitation Clinical Trial page
- Check3 days agoChange DetectedNew study sites added: Greenacres City, Florida; Sugar Land, Texas; Bayamón and San Juan, Puerto Rico. Some existing location entries were removed or relabeled during this update.SummaryDifference0.7%

- Check10 days agoChange DetectedNo changes to the trial’s design, eligibility criteria, or primary outcomes; updates consist of administrative metadata (Certification/Extension First Submitted, Certification/Extension Dates) and a revision label (Revision: v3.3.2) replacing v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check18 days agoChange DetectedRemoved the government funding operating-status notice from the page.SummaryDifference0.3%

- Check32 days agoChange DetectedThe comparison shows only minor layout adjustments with no addition or removal of core content. The study details, eligibility criteria, and location lists appear unchanged.SummaryDifference0.3%

- Check61 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference5%

- Check68 days agoChange DetectedMajor change: page now shows Revision: v3.1.0 and removes several drug-safety topics; indicates a content reorganization with version update rather than additions of new substantive information.SummaryDifference0.6%

Stay in the know with updates to AXS-05 in Alzheimer's Agitation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AXS-05 in Alzheimer's Agitation Clinical Trial page.